Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria

Goldberg, S. Nahum; Cardella, John F.; Charboneau, J. William; Dodd, Gerald D.; Dupuy, Damian E.; Gervais, Debra A.; Gillams, Alice; Kane, Robert A.; Lee, Fred T.; Livraghi, Tito; McGahan, John P.; Phillips, David A.; Rhim, Hyunchul; Silverman, Stuart G.; Solbiati, Luigi; Vogl, Thomas J.; Wood, Bradford J.; Vedantham, Suresh; Sacks, David

doi:10.1016/j.jvir.2009.04.011

Cited by 444 publications

(204 citation statements)

References 91 publications

Supporting

Mentioning

204

Contrasting

Order By: Relevance

“…Drug-eluting beads have similar efficacy to gealfoam-lipiodol with probably less adverse events. Both should be discouraged in decompensated liver disease and in case of macroscopic vascular invasion or extrahepatic spread [65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80] . An alternative to TACE is radioembolization.…”

Section: Hcc Treatmentmentioning

confidence: 99%

Management of hepatocellular carcinoma: Enlightening the gray zones

Mancuso¹

2013

WJH

View full text Add to dashboard Cite

Management of hepatocellular carcinoma (HCC) has been continuously evolving during recent years. HCC is a worldwide clinical and social issue and typically a complicates cirrhosis. The incidence of HCC is increasing, not only in the general population of patients with cirrhosis, but particularly in some subgroups of patients, like those with human immunodeficiency virus infection or thalassemia. Since a 3% annual HCC incidence has been estimated in cirrhosis, a bi-annual screening is generally suggested. The diagnostic criteria of HCC has recently had a dramatic evolution during recent years. HCC diagnosis is now made only on radiological criteria in the majority of the cases. In the context of cirrhosis, the universally accepted criteria for HCC diagnosis is contrast enhancement in arterial phase and washout in venous/late phase at imaging, the so called "typical pattern". However, recently updated guidelines slightly differ in diagnostic criteria. Apart from liver transplantation, the only cure of both HCC and underlying liver cirrhosis, all the other treatments have to match with higher rate of HCC recurrence. The latter can be classified into curative (resection and percutaneous ablation) and palliative treatments. The aim of this paper was to review the current knowledge on management of HCC and to enlighten the areas of uncertainty.

show abstract

Section: Hcc Treatmentmentioning

confidence: 99%

Management of hepatocellular carcinoma: Enlightening the gray zones

Mancuso¹

2013

WJH

View full text Add to dashboard Cite

show abstract

“…For example, flow in nearby vessels may act as a heat sink, diminishing the ability of the ablation probe to achieve a temperature of 60 o C in the area of interest (the temperature needed to achieve adequate thermal necrosis) (6). This heat sink effect may vary depending on the size of the vessel, the size of the tumor being treated, and the distance of the tumor with respect to the diameter of the vessel in question (6,16).…”

Section: Discussionmentioning

confidence: 99%

Local tumor progression patterns after radiofrequency ablation of colorectal cancer liver metastases

Napoleone

Kielar²,

Hibbert³

et al. 2016

Diagn Interv Radiol

View full text Add to dashboard Cite

“…Given that nine microwave systems are currently available on the market with differences in the frequency used, the power supplied, the diameter of the probe, the availability of a probe-cooling system or a miniaturized device to decrease MW reflection [77] , standardization of clinical criteria for reporting MWA outcomes is pivotal to compare the different methods.…”

Section: Clinical Application In Hccmentioning

confidence: 99%

“…According to the standardization of terminology and reporting criteria for image-guided tumor ablation by Goldberg et al [77] , a major complication is an event that…”

Section: Complicationsmentioning

confidence: 99%

“…With respect to major complications, data from meta-analysis of comparative studies between RFA and MWA shows that there are not significant differences between the 2 ablative techniques. However, it should be pointed out that there are still few studies focused on a large number of patients, and data are collected both from randomized and observational studies: These bias are still too strong to making a solid conclusion [77] . Major complications can be divided in vascular, biliary, mechanical, infectious and functional.…”

Section: Complicationsmentioning

confidence: 99%

See 1 more Smart Citation

Microwave ablation of hepatocellular carcinoma

Poggi¹

2015

WJH

100

View full text Add to dashboard Cite

thermal ablation techniques provide a valid nonsurgical treatment alternative, thanks to their minimal invasiveness, excellent tolerability and safety profile, proven efficacy in local disease control, virtually unlimited repeatability and cost-effectiveness. Different energy sources are currently employed in clinics as physical agents for percutaneous or intra-surgical thermal ablation of HCC nodules. Among them, radiofrequency (RF) currents are the most used, while microwave ablations (MWA) are becoming increasingly popular. Starting from the 90s', RF ablation (RFA) rapidly became the standard of care in ablation, especially in the treatment of small HCC nodules; however, RFA exhibits substantial performance limitations in the treatment of large lesions and/or tumors located near major heat sinks. MWA, first introduced in the Far Eastern clinical practice in the 80s', showing promising results but also severe limitations in the controllability of the emitted field and in the high amount of power employed for the ablation of large tumors, resulting in a poor coagulative performance and a relatively high complication rate, nowadays shows better results both in terms of treatment controllability and of overall coagulative performance, thanks to the improvement of technology. In this review we provide an extensive and detailed overview of the key physical and technical aspects of MWA and of the currently available systems, and we want to discuss the most relevant published data on MWA treatments of HCC nodules in regard to clinical results and to the type and rate of complications, both in absolute terms and in comparison with RFA. AbstractAlthough surgical resection is still the optimal treatment option for early-stage hepatocellular carcinoma (HCC) in patients with well compensated cirrhosis, TOPIC HIGHLIGHT Microwave ablation of hepatocellular carcinoma Advances in Hepatocellular Carcinomaalready available about a direct comparison between radiofrequency ablation and microwave ablation; in this review we provide an extensive and detailed overview on the technical and engineering aspects of microwave devices, and we critically expose the most relevant clinical data about the experience in microwave ablation, also by making a comparison with radiofrequency ablation.

show abstract

Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria

Cited by 444 publications

References 91 publications

Management of hepatocellular carcinoma: Enlightening the gray zones

Management of hepatocellular carcinoma: Enlightening the gray zones

Local tumor progression patterns after radiofrequency ablation of colorectal cancer liver metastases

Microwave ablation of hepatocellular carcinoma

Contact Info

Product

Resources

About